Your session is about to expire
← Back to Search
Stretching Treatments for Apophysitis
Study Summary
This trial is comparing three different treatments for apophysitis of the lower extremity in adolescents to see which is most effective in reducing pain and allowing return to sports and activities.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with OSS, SLJ, or Sever's disease.I've had an injury to a joint that stopped me from sports or activities for over a week.I have been diagnosed with OSS, SLJ, or Sever's disease.I have been treated for OSS, SLJ, or Sever's disease in the past.
- Group 1: Symptomatic Treatment
- Group 2: Static Stretch
- Group 3: Active Elongation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What criteria must individuals satisfy in order to participate in this trial?
"For this clinical trial, 90 adolescents with osteitis between the ages of 8 and 17 are being recruited. Notably, applicants must have consistent access to the World Wide Web."
Does this medical experiment currently accept participants?
"Unfortunately, according to clinicaltrials.gov this trial is no longer recruiting new patients. The posting was first made on October 1st 2012 and the last edits were done by April 5th 2013. Despite there being no further recruitment, 1399 other trials are currently open for enrollment of participants."
Does this research endeavor embrace participants aged 40 and beyond?
"This trial is only open to patients aged 8 to 17. According to the same database, there are 379 trials for minors and 989 for those above 65 years of age."
Share this study with friends
Copy Link
Messenger